Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) is having a relatively strong start to the trading session in the pre-market hours this morning. Interestingly the stock soared in the pre-market yesterday, before tanking and closing the day deep in the red. Nonetheless, I believe that the declines are nothing more than a buying opportunity and that the … Read more
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has entered into a licensing agreement with Jannsen Pharmaceuticals, part of the Johnson & Johnson (JNJ) family of companies. Of course, the agreement excited investors, sending the stock on … Read more
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) is flying early on in the trading session this morning, and for good reason. The company released new clinical data surrounding an RNAi therapeutic it is developing and will be presenting this data soon, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: The data; … Read more
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that it has presented data with regard to its candidate known as ARC-520. Of course, the announcement excited investors, causing the stock to head upward. Today, we’ll talk about: The presentation … Read more
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) is having an overwhelmingly strong start to the trading session, and for good reason. The company announced a clinical update surrounding a key Phase 1/2 clinical study. Of course, the update was positive, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the … Read more
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The company issued a press release informing investors of the pricing of a public offering. Of course, this led to fears of dilution, causing declines in the value of the stock. Today, we’ll talk … Read more
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) | Amgen, Inc. (NASDAQ: AMGN) Arrowhead Pharmaceuticals is having a strong day in the market today, and for good reason. The company announced license and collaboration agreements that it has penned with Amgen. Today, we’ll talk about the details of the agreements, what we’re seeing from the stock as a … Read more
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Arrowhead Pharmaceuticals is having a strong day in the market today, and for good reason. The company announced that it will be giving 3 presentations relatively soon. As a result, investor excitement is pushing the stock up in a big way. Today, we’ll talk about the presentations the company will … Read more
The Dow Jones and the rest of the US market is, and has been, having a rough time. In fact, for months now, we’ve seen nothing, but declines in the market. However, there is one industry that’s presenting gems as of late. That’s the biotech industry! Today, we’ll talk about why US markets are falling … Read more
Arrowhead Research Corp (NASDAQ: ARWR) Arrowhead Research is having a great start to Thursday’s trading session as investors anticipate a big event. Today is the day of the ARWR analyst day; an event that will begin at 11:00 a.m. Eastern Time. Today’s event was designed as an outlet for Arrowhead Research to release top-line results … Read more